The ERK5 pathway also appears to play a role in mediating chemoresistance and contributes to neuregulin signalling in breast-cancer cells overexpressing ErbB2 (Weldon et al., 2002 ▸; Esparís-Ogando et al., 2002 ▸). This evidence concerns the gene MAPK7 and breast carcinoma.